Newsletter Archive

  1. 06.23.26 -- Avoiding Common Pitfalls In CDMO–Sponsor Relationships Through Integrated Execution Models 6/23/2026
    06/23/26 Bioprocess Online Newsletter
  2. 06.22.26 -- On The Ground At NextGen Biomed 2026 6/22/2026
    06/22/26
  3. 06.22.26 -- Simplify The Journey Of Advancing Your Therapies To Patients 6/22/2026

    06/22/26 Bioprocess Online Newsletter

  4. 06.20.26 -- FDA Codifies CMC Flexibility For CGTs, Assay Selection, And Comparing Analytical-Validation Guidelines 6/20/2026
    06/20/26 Bioprocess Online Newsletter
  5. 06.19.26 -- STREAM Edition: Democratizing Digital Tools 6/19/2026

    06/19/26 Bioprocess Online Newsletter

  6. 06.19.26 -- Inside AstraZeneca's Fully Electrified Cell Therapy Facility 6/19/2026
    06/19/26 Bioprocess Online Newsletter
  7. 06.18.26 -- Scale Vaccine Production With Proven Cell Culture Solutions 6/18/2026

    06/18/26 Bioprocess Online Newsletter

  8. 06.18.26 -- Where Does 3D-Printed Single-Use Tech Fit In The Development Pipeline? 6/18/2026
    06/18/26 Bioprocess Online Newsletter
  9. 06.17.26 -- Tools And Technologies Enabling Next-Generation Cell Therapies 6/17/2026

    06/17/26 Bioprocess Online Newsletter

  10. 06.17.26 -- Downstream Decisions To Maximize Viral Vector Yields And Reduce COGs 6/17/2026
    06/17/26 Bioprocess Online Newsletter